3 studies found for:    9704717 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
Condition: ErbB2-Positive Stage I-III Breast Cancer
Intervention: Drug: paclitaxel/carboplatin/lapatinib
2 Recruiting Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Metformin;   Drug: Placebo
3 Recruiting Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel;   Procedure: Surgery D30 after chemotherapy

Indicates status has not been verified in more than two years